Chinese Med J Peking
-
Chinese Med J Peking · Jul 2008
Randomized Controlled Trial Multicenter StudyMulticenter clinical study on the efficacy and safety of inhalable insulin aerosol in the treatment of type 2 diabetes.
A new inhalable insulin aerosol (Inh-Ins) was developed in China. The aim of this multicenter clinical study was to evaluate the efficacy and safety of this new Inh-Ins as a treatment of type 2 diabetes. Regular porcine insulin (RI) was used as a control. ⋯ Inh-Ins was effective in decreasing HbA1c like the RI. It was better in lowering the FPG and the 1hPBG than the RI. Its main side effects were coughing, excessive sputum, and hypoglycemia. Also, Inh-Ins slightly impaired DLco.